Derivative exercise or conversion — not an open-market buy.
Traded Nov 20, 2025 · Filed Nov 25, 2025
Sold under a plan set up in advance, so the timing wasn't a fresh decision
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$13,698
Shares × reported transaction price
17 days after results of Nov 3, 2025, 74 days before results of Feb 2, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $155.745 on Nov 20, 2025, 154% above its 52-week low and 25% below its high, after a 16% drop over the previous 30 trading days
52-week range $61.36 (Nov 21, 2024) to $207.18 (Nov 3, 2025), 65% of the way up, from 250 adjusted closes. 30 trading days earlier: $185.47 on Oct 9, 2025. Describes the past only, not a forecast
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +4.4% | +1.0% | +3.4% |
| 30 days | +15.4% | +2.3% | +13.1% |
| 90 days | -20.1% | +1.1% | -21.2% |
| 180 days | -16.5% | +11.2% | -27.7% |
Past results only. Not a forecast.
Derivative exercise or conversion — not an open-market buy.
Officer sold ~$1.67M of Palantir
Scheduled in advanceGift or transfer — classified separately from trades.